FOCAL NODULAR HYPERPLASIA side effect
What is FOCAL NODULAR HYPERPLASIA ?Drugs associated with FOCAL NODULAR HYPERPLASIA
AOTAL ELOXATIN FLUOXETINE NIASPAN NUVARING PRINIVIL VIDEXFOCAL NODULAR HYPERPLASIA : Prinivil Side Effects Report #5688730-5
Physician from NETHERLANDS reported PRINIVIL problem on Mar 17, 2008. Male patient, 50 years of age, was treated with PRINIVIL. After drug was administered, patient experienced the following problems/side effects: focal nodular hyperplasia, hepatic failure, oesophageal varices haemorrhage, portal hypertension, . PRINIVIL dosage: unknown. During the same period patient was treated with DIDANOSINE, NIFEDIPINE, TENOFOVIR, LAMIVUDINE, LOPINAVIR AND RITONAVIR, NEVIRAPINE. Patient recovered.
FOCAL NODULAR HYPERPLASIA : Nuvaring Side Effects Report #5615007-6
NUVARING problem was reported by a Consumer or non-health professional from GERMANY on Jan 22, 2008. Female patient, 28 years of age, was diagnosed with contraception and was treated with NUVARING. After drug was administered, patient experienced the following problems/side effects: focal nodular hyperplasia, haemangioma of liver, . NUVARING dosage: unknown. During the same period patient was treated with LOVELLE, PRAMINO, FEMOVAN. Patient recovered.
FOCAL NODULAR HYPERPLASIA : Eloxatin Side Effects Report #5626597-1
Health Professional from BELGIUM reported ELOXATIN problem on Feb 05, 2008. Female patient was diagnosed with metastases to liver and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: focal nodular hyperplasia, hepatic failure, malignant neoplasm progression, portal hypertension, . ELOXATIN dosage: unknown. During the same period patient was treated with EPREX, MYOLASTAN, FRAXIPARINE, LITICAN, NEUPOGEN, DEXAMETHASONE, PYRIDOXINE, ZOFRAN. Patient recovered.
FOCAL NODULAR HYPERPLASIA : Nuvaring Side Effects Report #5518054-8
NUVARING problem was reported by a Consumer or non-health professional from GERMANY on Oct 26, 2007. Female patient, 28 years of age, was diagnosed with contraception and was treated with NUVARING. After drug was administered, patient experienced the following problems/side effects: focal nodular hyperplasia, haemangioma of liver, . NUVARING dosage: unknown. During the same period patient was treated with LOVELLE. Patient recovered.
FOCAL NODULAR HYPERPLASIA : Videx Side Effects Report #5521652-9
Physician from SPAIN reported VIDEX problem on Nov 16, 2007. Female patient was diagnosed with hiv infection and was treated with VIDEX. After drug was administered, patient experienced the following problems/side effects: focal nodular hyperplasia, . VIDEX dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, KALETRA. Patient was hospitalized. Patient recovered.
FOCAL NODULAR HYPERPLASIA : Aotal Side Effects Report #5423125-0
AOTAL problem was reported by a Health Professional from FRANCE on Aug 08, 2007. Female patient, 65 years of age, was diagnosed with alcoholism, hypercholesterolaemia and was treated with AOTAL. After drug was administered, patient experienced the following problems/side effects: focal nodular hyperplasia, hepatic failure, hepatitis fulminant, . AOTAL dosage: 666 MG TID PO. During the same period patient was treated with DISULFIRAM, ATORVASTATIN CALCIUM, XANAX. Patient died on 06/28/2007.
FOCAL NODULAR HYPERPLASIA : Fluoxetine Side Effects Report #5503542-0
Consumer or non-health professional from UNITED KINGDOM reported FLUOXETINE problem on Oct 18, 2007. Female patient, 57 years of age, was treated with FLUOXETINE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, focal nodular hyperplasia, oxygen saturation increased, pancreatitis acute, respiration abnormal, . FLUOXETINE dosage: 20 MG; QD; PO. During the same period patient was treated with LISINOPRIL, BENDROFLUTHIAZIDE. Patient was hospitalized. Patient recovered.
FOCAL NODULAR HYPERPLASIA : Niaspan Side Effects Report #5400005-8
NIASPAN problem was reported by a Health Professional from SWITZERLAND on July 12, 2007. Male patient, 57 years of age, was treated with NIASPAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, duodenal ulcer haemorrhage, focal nodular hyperplasia, hepatocellular damage, . NIASPAN dosage: 500 MG QD PO. During the same period patient was treated with MARCUMAR, ASPIRIN, METO ZEROK, INEGY, IRBESARTAN, AMIODARON, NEXIUM. Patient was hospitalized. Patient recovered.
FOCAL NODULAR HYPERPLASIA : Niaspan Side Effects Report #5400005-8
Health Professional from SWITZERLAND reported NIASPAN problem on July 12, 2007. Male patient, 57 years of age, was treated with NIASPAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, duodenal ulcer haemorrhage, focal nodular hyperplasia, hepatocellular damage, . NIASPAN dosage: 500 MG QD PO. During the same period patient was treated with MARCUMAR, ASPIRIN, METO ZEROK, INEGY, IRBESARTAN, AMIODARON, NEXIUM. Patient was hospitalized. Patient recovered.